These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20550062)

  • 21. Gene-mediated inhibition of the b-adrenergic receptor kinase: a new therapeutic strategy for heart failure.
    Tevaearai HT; Eckhart AD; Koch WJ
    Minerva Cardioangiol; 2001 Dec; 49(6):389-94. PubMed ID: 11733734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-adrenergic receptor antagonism preserves myocardial function after brain death in a porcine model.
    McLean KM; Pandalai PK; Pearl JM; Bulcao CF; Lyons JM; Wagner CJ; Akhter SA; Duffy JY
    J Heart Lung Transplant; 2007 May; 26(5):522-8. PubMed ID: 17449424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of protein kinase C alpha improves myocardial beta-adrenergic receptor signaling and ventricular function in a model of myocardial preservation.
    D'Souza KM; Petrashevskaya NN; Merrill WH; Akhter SA
    J Thorac Cardiovasc Surg; 2008 Jan; 135(1):172-9, 179.e1. PubMed ID: 18179937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-adrenergic pathways in human heart failure.
    Sucharov CC
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):119-24. PubMed ID: 17187463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy.
    El-Armouche A; Wittköpper K; Degenhardt F; Weinberger F; Didié M; Melnychenko I; Grimm M; Peeck M; Zimmermann WH; Unsöld B; Hasenfuss G; Dobrev D; Eschenhagen T
    Cardiovasc Res; 2008 Dec; 80(3):396-406. PubMed ID: 18689792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo inhibition of elevated myocardial beta-adrenergic receptor kinase activity in hybrid transgenic mice restores normal beta-adrenergic signaling and function.
    Akhter SA; Eckhart AD; Rockman HA; Shotwell K; Lefkowitz RJ; Koch WJ
    Circulation; 1999 Aug; 100(6):648-53. PubMed ID: 10441103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alteration of the beta-adrenergic signaling pathway in human heart failure.
    Hamdani N; Linke WA
    Curr Pharm Biotechnol; 2012 Oct; 13(13):2522-31. PubMed ID: 22280427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The function of beta receptors in chronic left ventricular insufficiency].
    Cabanes L; Weber S; Guérin F
    Rev Prat; 1990 Oct; 40(23 Suppl):13-7. PubMed ID: 1980029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
    Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gβγ-independent recruitment of G-protein coupled receptor kinase 2 drives tumor necrosis factor α-induced cardiac β-adrenergic receptor dysfunction.
    Vasudevan NT; Mohan ML; Gupta MK; Martelli EE; Hussain AK; Qin Y; Chandrasekharan UM; Young D; Feldman AM; Sen S; Dorn GW; Dicorleto PE; Naga Prasad SV
    Circulation; 2013 Jul; 128(4):377-87. PubMed ID: 23785004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting myocardial beta-adrenergic receptor signaling and calcium cycling for heart failure gene therapy.
    Pleger ST; Boucher M; Most P; Koch WJ
    J Card Fail; 2007 Jun; 13(5):401-14. PubMed ID: 17602988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Alterations in sympathoadrenal system in congestive heart failure].
    Yoshikawa T
    Nihon Rinsho; 2003 May; 61(5):739-44. PubMed ID: 12754996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction.
    White DC; Hata JA; Shah AS; Glower DD; Lefkowitz RJ; Koch WJ
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5428-33. PubMed ID: 10779554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-adrenergic receptors and receptor signaling in heart failure.
    Post SR; Hammond HK; Insel PA
    Annu Rev Pharmacol Toxicol; 1999; 39():343-60. PubMed ID: 10331088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic regulation of phosphoinositide 3-kinase-gamma activity and beta-adrenergic receptor trafficking in end-stage human heart failure.
    Perrino C; Schroder JN; Lima B; Villamizar N; Nienaber JJ; Milano CA; Naga Prasad SV
    Circulation; 2007 Nov; 116(22):2571-9. PubMed ID: 17998459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. betaARK1 inhibition improves survival in a mouse model of heart failure induced by myocardial infarction.
    Suzuki Y; Nakano K; Sugiyama M; Imagawa J
    J Cardiovasc Pharmacol; 2004 Sep; 44(3):329-34. PubMed ID: 15475830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in adrenergic receptor signaling in heart failure.
    Lamba S; Abraham WT
    Heart Fail Rev; 2000 Mar; 5(1):7-16. PubMed ID: 16228912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of beta-adrenergic receptor signaling and desensitization in heart failure: new concepts and prospects for treatment.
    Tilley DG; Rockman HA
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):417-32. PubMed ID: 16716102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pathophysiology of chronic heart failure].
    Weil J; Schunkert H
    Clin Res Cardiol; 2006; 95 Suppl 4():1-15; quiz 16-7. PubMed ID: 16598604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic manipulation of beta-adrenergic signalling in heart failure.
    Davidson MJ; Koch WJ
    Acta Physiol Scand; 2001 Sep; 173(1):145-50. PubMed ID: 11678737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.